Genpact (NYSE:G – Get Free Report) had its target price lifted by equities researchers at Susquehanna from $40.00 to $42.00 in a report released on Friday, Benzinga reports. The firm presently has a “neutral” rating on the business services provider’s stock. Susquehanna‘s price objective indicates a potential upside of 2.04% from the stock’s previous close.
Several other equities research analysts also recently weighed in on the company. BMO Capital Markets reissued a “market perform” rating and issued a $40.00 price objective on shares of Genpact in a report on Friday, August 7th. TD Cowen lifted their target price on shares of Genpact from $42.00 to $43.00 and gave the company a “buy” rating in a report on Friday, August 7th. JPMorgan Chase & Co. upped their price target on shares of Genpact from $40.00 to $45.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. Citigroup increased their price target on shares of Genpact from $32.00 to $36.00 and gave the stock a “neutral” rating in a research note on Friday, August 7th. Finally, Wall Street Zen upgraded shares of Genpact from a “hold” rating to a “buy” rating in a research note on Saturday, October 3rd. Two investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $41.00.
Check Out Our Latest Stock Report on Genpact
Genpact Price Performance
Genpact stock opened at $41.16 on Friday. The stock has a market cap of $6.88 billion, a P/E ratio of 12.21, a price-to-earnings-growth ratio of 1.08 and a beta of 0.53. The company has a fifty day simple moving average of $36.44 and a 200-day simple moving average of $35.54. Genpact has a 12-month low of $26.85 and a 12-month high of $48.64. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.44.
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The business services provider reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03. The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.38 billion. Genpact had a return on equity of 23.34% and a net margin of 11.04%. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.97 earnings per share. Equities analysts expect that Genpact will post 3.66 EPS for the current fiscal year.
Insiders Place Their Bets
In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total transaction of $229,252.73. Following the completion of the sale, the senior vice president directly owned 70,253 shares of the company’s stock, valued at approximately $2,601,468.59. This trade represents a 8.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.58% of the company’s stock.
Institutional Investors Weigh In On Genpact
Several large investors have recently modified their holdings of G. Illinois Municipal Retirement Fund grew its position in Genpact by 0.9% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 119,753 shares of the business services provider’s stock valued at $3,896,000 after buying an additional 1,103 shares during the last quarter. Csenge Advisory Group purchased a new position in Genpact during the 3rd quarter worth $244,000. Flynn Zito Capital Management LLC lifted its stake in shares of Genpact by 4.8% in the 3rd quarter. Flynn Zito Capital Management LLC now owns 8,910 shares of the business services provider’s stock worth $290,000 after acquiring an additional 408 shares during the period. Ballast Asset Management LP lifted its stake in shares of Genpact by 16.1% in the 3rd quarter. Ballast Asset Management LP now owns 138,556 shares of the business services provider’s stock worth $4,507,000 after acquiring an additional 19,230 shares during the period. Finally, Leuthold Group LLC acquired a new stake in shares of Genpact in the 3rd quarter worth $438,000. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Key Headlines Impacting Genpact
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Genpact reported third-quarter adjusted earnings of $1.07 per share, ahead of estimates of $1.04–$1.05. Revenue was $1.39 billion, up 7.3% year over year and slightly above expectations. Genpact Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Advanced Technology Solutions revenue grew 30% year over year, supporting the quarter’s performance. Genpact also raised its 2026 guidance for gross margin and adjusted diluted EPS, signaling confidence in profitability. Genpact Reports Third Quarter 2026 Results
- Positive Sentiment: Needham & Company raised its price target to $55 from $45 and maintained a Buy rating. The new target represents about 33.6% upside from the cited $41.16 reference price. Needham & Company recommendations
Genpact Company Profile
Genpact (NYSE: G) is a global professional services and business process management company that helps organizations improve operations through digital transformation, data and analytics, artificial intelligence, and industry-specific expertise. The company combines technology with operational services to support clients across core business functions.
Its offerings include finance and accounting, procurement, supply chain management, customer experience, risk and compliance, insurance operations, and banking and capital markets services.
Further Reading
- Five stocks we like better than Genpact
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
